يعرض 1 - 10 نتائج من 436 نتيجة بحث عن '"Heymach, J."', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
    229P Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies

    المؤلفون: Di Federico, A., Hong, L., Elkrief, A., Thummalapalli, R., Ricciuti, B., Alessi, J., Gogia, P., Pecci, F., Gandhi, M., Ladanyi, M., Zhang, J., Gibbons, D., Heymach, J., Nishino, M., Sholl, L., Awad, M., Arbour, K.C., Schoenfeld, A., Vokes, N., Luo, J.

    المساهمون: Novartis

    المصدر: ESMO Open ; volume 9, page 102879 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102879
    https://api.elsevier.com/content/article/PII:S2059702924006471?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702924006471?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    34P Updated data from Beamion LUNG-1, a phase (ph) Ia/b trial of the HER2-specific tyrosine kinase inhibitor (TKI), zongertinib (BI 1810631), in patients (pts) with HER2 mutation-positive (m+) NSCLC

    المؤلفون: Wu, Y-L., Opdam, F., Barve, M., Tu, H., Berz, D., Rohrbacher, M., Sadrolhefazi, B., Serra, J., Yoh, K., Yamamoto, N., Heymach, J.

    المساهمون: Boehringer Ingelheim

    المصدر: ESMO Open ; volume 9, page 102613 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102613
    https://api.elsevier.com/content/article/PII:S2059702924003818?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702924003818?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    123P Updated safety of perioperative durvalumab for resectable NSCLC in AEGEAN

    المؤلفون: Urban, L., Winder, T., Reck, M., Zukov, R., Garbaos, G.E., Tran, T.V., Lee, K-Y., Pasello, G., Fouad, T., Morgan, C., Doake, R., Heymach, J.

    المصدر: ESMO Open ; volume 9, page 102702 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102702
    https://api.elsevier.com/content/article/PII:S2059702924004708?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702924004708?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    24P EGFR PACC mutations occur more frequently in compound than classical mutations with improved responses to TKIs

    المؤلفون: Le, X., Stamboulian, M., Borgeaud, M., Nilsson, M., Heeke, S., Ravichandran, A., Lawson, J., Lewis, C., Drusbosky, L., Heymach, J., Addeo, A.

    المصدر: ESMO Open ; volume 9, page 102603 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102603
    https://api.elsevier.com/content/article/PII:S2059702924003715?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702924003715?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    16P A phase Ib/II trial to evaluate safety and efficacy of aurora kinase inhibitor LY3295668 in combination with osimertinib for patients with EGFR-mutant non-small cell lung cancer

    المؤلفون: Le, X., Elamin, Y.Y., Altan, M., Blumenschein, G., Byers, L.A., Cascone, T., Skoulidis, F., Gay, C., Tsao, A.S., Gibbons, D., Negrao, M.V., Vokes, N., Zhang, J., Heeke, S., Rotow, J., Jänne, P.A., Pellini, B., Tu, J., Gray, J.E., Heymach, J.

    المصدر: ESMO Open ; volume 9, page 102595 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102595
    https://api.elsevier.com/content/article/PII:S2059702924003636?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702924003636?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results

    المؤلفون: Garon, E B, Reck, M, Nishio, K, Heymach, J V, Nishio, M, Novello, S, Paz-Ares, L, Popat, S, Aix, S Ponce, Graham, H, Butts, B D, Visseren-Grul, C, Nakagawa, K

    المساهمون: Garon, E B, Reck, M, Nishio, K, Heymach, J V, Nishio, M, Novello, S, Paz-Ares, L, Popat, S, Aix, S Ponce, Graham, H, Butts, B D, Visseren-Grul, C, Nakagawa, K

    مصطلحات موضوعية: EGFR, NSCLC, biomarker, erlotinib, next-generation sequencing, ramucirumab

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37390764; volume:8; issue:4; firstpage:1; lastpage:13; numberofpages:13; journal:ESMO OPEN; https://hdl.handle.net/2318/1917231Test

    الإتاحة: https://doi.org/10.1016Test/j.esmoop.2023.101580
    https://hdl.handle.net/2318/1917231Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    40P Updated data from the phase I Beamion Lung 1 trial of BI 1810631, a HER2 TKI, in patients (pts) with advanced solid tumours with HER2 aberrations

    المؤلفون: Opdam, F., Heymach, J., Barve, M., Tu, H-Y., Wu, Y-L., Gibson, N.J., Sadrolhefazi, B., Serra, J., Yoh, K., Yamamoto, N.

    المصدر: Journal of Thoracic Oncology ; volume 18, issue 4, page S63-S64 ; ISSN 1556-0864

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

    الإتاحة: https://doi.org/10.1016/s1556-0864Test(23)00294-0
    https://api.elsevier.com/content/article/PII:S1556086423002940?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S1556086423002940?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    PP01.18 Surgical Resection after Targeted Therapy in Stage IV NSCLC: Nuances and Considerations

    المؤلفون: Antonoff, M., Deboever, N., Swisher, S., Sepesi, B., Altan, M., Vaporciyan, A., Heymach, J., Gandhi, S., Elamin, Y.

    المصدر: Journal of Thoracic Oncology ; volume 18, issue 3, page e18 ; ISSN 1556-0864

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.jtho.2022.09.044
    https://api.elsevier.com/content/article/PII:S1556086422016306?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S1556086422016306?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    779TiP Commencement of first-in-human phase I/II TCR-T clinical trial targeting shared tumor-specific hotspot mutations in solid tumors

    المؤلفون: Morelli, M.P., Negrao, M.V., Jazaeri, A., Johnson, B., Kebriaei, P., Deniger, D., Collinson-Pautz, M., Demars, N., Heymach, J., Kopetz, S.

    المصدر: Annals of Oncology ; volume 33, page S897 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016Test/j.annonc.2022.07.905
    https://api.elsevier.com/content/article/PII:S0923753422027569?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753422027569?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    EP08.02-049 A Phase I Trial of the HER2 Exon 20 Inhibitor, BI 1810631, In Patients With Advanced Solid Tumors With HER2 Aberrations

    المؤلفون: Opdam, F., Heymach, J., Barve, M., Gibson, N., Sadrolhefazi, B., Serra, J., Yamamoto, N., Yoh, K., Wu, Y.-L.

    المصدر: Journal of Thoracic Oncology ; volume 17, issue 9, page S421-S422 ; ISSN 1556-0864

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

    الإتاحة: https://doi.org/10.1016Test/j.jtho.2022.07.731
    https://api.elsevier.com/content/article/PII:S1556086422010723?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S1556086422010723?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث